Semaglutide GLP-1, initially developed for managing type 2 diabetes, has been FDA-approved since June 2021 for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related condition such as hypertension, type 2 diabetes, or hyperlipidemia
Direct Meds focuses on a simplified ordering experience with fewer options but faster processing
Oui, tout fait
Recent epidemiological research, including studies analysing electronic health records, has identified associations between GLP-1 agonist use and reduced incidence of depression diagnoses or antidepressant prescriptions
When ingested in the form of glucosefructose mixtures, not only is the ingestion rate necessary to rapidly replete more tolerable due to lower gut discomfort, but total body glycogen status can also be enhanced over glucose (polymer) ingestion alone, due to greater liver glycogen repletion [R]
Fats Healthy fats are vital for GLP-1 users as they help regulate blood sugar and keep you feeling full longer